NasdaqCM - Nasdaq Real Time Price USD
Brainstorm Cell Therapeutics Inc. (BCLI)
0.8750
+0.0059
+(0.68%)
As of 9:30:01 AM EDT. Market Open.
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
1,832
--
8,451
29,277
Total Liabilities Net Minority Interest
9,596
--
11,466
9,935
Total Equity Gross Minority Interest
-7,764
--
-3,015
19,342
Total Capitalization
-7,764
--
-3,015
19,342
Common Stock Equity
-7,764
--
-3,015
19,342
Capital Lease Obligations
720
--
4,093
5,079
Net Tangible Assets
-7,764
--
-3,015
19,342
Working Capital
-8,593
--
-5,694
16,963
Invested Capital
-7,764
--
-3,015
19,342
Tangible Book Value
-7,764
--
-3,015
19,342
Total Debt
720
--
4,093
5,079
Share Issued
5,308.1300
4,032.6130
2,446.2710
2,426.7600
Ordinary Shares Number
5,308.1300
4,032.6130
2,446.2710
2,426.7600
12/31/2021 - 10/7/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BLRX BioLineRx Ltd.
2.9267
-2.44%
PLUR Pluri Inc.
6.21
-8.00%
SVRA Savara Inc.
3.2300
-0.62%
VYGR Voyager Therapeutics, Inc.
3.5200
+0.86%
CERO CERo Therapeutics Holdings, Inc.
1.2380
+54.75%
MTVA MetaVia Inc.
0.7751
-4.69%
GUTS Fractyl Health, Inc.
1.3300
0.00%
VRPX Virpax Pharmaceuticals, Inc.
0.2600
+10.64%
PPBT Purple Biotech Ltd
2.6724
-4.90%
ENLV.TA Enlivex Therapeutics Ltd.
335.90
+1.60%